Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BalchemFRA:BL9B -0.13%92 EV-to-EBIT is 26.05 as of Aug. 19, 2026, which is 18% below its 10-year median of 31.61. GuruFocus rates FRA:BL9B with a GF Score™ of 92/100 and a GF Value™ of €155.74 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,258 Chemicals companies, Balchem ranks worse than 65.1% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Balchem's Enterprise Value is €4,961.0 Mil.
Balchem's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €190.5 Mil. Therefore, Balchem's EV-to-EBIT for today is 26.05.
The historical rank and industry rank for Balchem's EV-to-EBIT or its related term are showing as below:
FRA:BL9B'
s EV-to-EBIT Range Over the Past 10 Years
Min: 23.56 Med: 31.61 Max: 44.72
Current: 25.95
During the past 13 years, the highest EV-to-EBIT of Balchem was 44.72. The lowest was 23.56. And the median was 31.61.
FRA:BL9B's EV-to-EBIT is ranked worse than 65.1% of 1258
companies
in the Chemicals industry
Industry Median: 17.465
vs FRA:BL9B: 25.95
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Balchem's Enterprise Value for the quarter that ended in Jun. 2026 was €4,684.9 Mil.
Balchem's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €190.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balchem EV-to-EBIT Related Terms
Balchem EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Balchem's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Balchem's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balchem EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Balchem's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Balchem's EV-to-EBIT falls into.
Balchem's current Enterprise Value is €4,961.0 Mil.
Balchem's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €190.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balchem (FRA:BL9B) has a EV-to-EBIT of 26.05 as of Aug. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Balchem and its competitors. This is 18% below median its historical median of 31.61. Over the past decade, Balchem's EV-to-EBIT has ranged from 23.56 to 44.72. According to the industry distribution chart, Balchem ranks #819 out of 1258 companies in the Chemicals industry, placing it in the top 65.1%.
Is Balchem's EV-to-EBIT too high?
Balchem's current EV-to-EBIT of 26.05 is 18% below median its 10-year median of 31.61. Over the past 10 years, this metric has ranged from a low of 23.56 to a high of 44.72. The Chemicals industry median EV-to-EBIT is 17.47. Balchem's value of 26.05 is 49.2% above this industry median. Based on the distribution chart, Balchem ranks #819 out of 1258 companies in the Chemicals industry, which is below the industry midpoint. Overall, Balchem has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Balchem's EV-to-EBIT compare to SXT and PRM?
According to the Chemicals industry distribution chart, Balchem ranks #819 out of 1258 companies for EV-to-EBIT. This places Balchem in the lower half of its industry. The industry median EV-to-EBIT is 17.47. Balchem's value of 26.05 is 49.2% above this benchmark. Historically, Balchem's own EV-to-EBIT has ranged from 23.56 to 44.72 over the past decade. While the company's 10-year median is 31.61 vs. the industry median of 17.47, Balchem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.47, based on 1,258 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balchem's current EV-to-EBIT of 26.05 is 49.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Balchem and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balchem's current EV-to-EBIT is 26.05, which is 18% below median its own 10-year median of 31.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balchem stock overvalued right now?
Based on GuruFocus' analysis, Balchem (FRA:BL9B) is currently considered Fairly Valued. The stock's GF Value™ is €155.74, compared to a current price of €151.50 — trading 2.7% below its estimated fair value. The current EV-to-EBIT is 26.05, which is 18% below median its 10-year median of 31.61 and 49.2% above the Chemicals industry median of 17.47. Balchem's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Balchem (FRA:BL9B), the current EV-to-EBIT is 26.05 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Balchem (FRA:BL9B) Overvalued in 2026?
Based on GuruFocus' analysis, Balchem stock appears to be undervalued.
The current stock price of €151.50 is trading 2.7% below its estimated GF Value™ of €155.74.
GuruFocus considers Balchem to be Fairly Valued.
Key valuation signals for FRA:BL9B:
EV-to-EBIT: 26.05 (18% below median its 10-year median of 31.61)
GF Value™: €155.74 vs. price of €151.50 (2.7% below fair value)
Industry Position: 49.2% above the Chemicals median (#819 of 1258)
No single metric tells the full story. See the FRA:BL9B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
92GF Score
Get the complete analysis for FRA:BL9B
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:BL9B has been successfully added to your 
